Neuropeptide FF vs Neuropeptide S — mechanism, half-life, dosing, and research status compared. Which is right for your protocol?
Neuropeptide FF (NPFF) is an endogenous octapeptide first isolated from bovine brain in 1985 and recognized as a key endogenous anti-opioid system component. NPFF is produced in the hypothalamus, brain stem, and spinal cord and acts on NPFF1 and NPFF2 receptors (GPCRs) to oppose ...
Calculate Neuropeptide FF dose →Neuropeptide S (NPS) is a 20-amino acid peptide discovered in 2004 that acts on the NPS receptor (NPSR1), a Gq/Gs-coupled GPCR with highest expression in amygdala, hypothalamus, and brainstem arousal centers. NPS produces a distinctive combination of simultaneous wakefulness prom...
Calculate Neuropeptide S dose →| Parameter | Neuropeptide FF | Neuropeptide S |
|---|---|---|
| Category | Neuropeptide | Neuropeptide |
| Research | Research | Preclinical |
| Half-Life | Short (minutes) | Short (minutes, CNS) |
| Typical Dose | 0.1-10 nmol (central, animal) | 0.1-10 nmol (ICV, animal) |
| Frequency | Variable | Variable |
| Route | Intrathecal, Intracerebroventricular (research) | Intracerebroventricular (animal research) |
| FDA Status | Not approved | Not approved |
Use ASCEND's free reconstitution calculator to get exact syringe draw amounts for your vial.
For research use only. Not medical advice. ASCEND does not conduct or endorse any specific research protocol. Always consult relevant scientific literature and regulatory guidelines.